Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lernapharm (LORIS) Inc. is a Canadian pharmaceutical manufacturer specializing in the development and production of antiseptic and disinfecting products. Founded in 2001 and headquartered in Montreal, the company produces a comprehensive range of products including povidone-iodine, chlorhexidine gluconate, and isopropyl alcohol-based solutions, swabs, and wipes. Their portfolio serves critical needs in preoperative skin preparation, infection control in healthcare settings, and personal hygiene. Lernapharm operates an ISO-certified and GMP-compliant facility with extensive R&D and manufacturing capabilities, including specialized clean rooms and liquid filling lines. The company provides advanced, cost-efficient medical devices and pharmaceutical formulations to both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LernaPharm Loris.